Exagen Inc Cash Flow-to-Debt Ratio
Exagen Inc cash flow-to-debt ratio. Exagen Inc (XGN) has a Cash Flow-to-Debt Ratio of 0.10x as of June 2026, meaning its operating cash flow of $3.99 Million could theoretically repay 0% of its total liabilities ($39.72 Million) in one year. See XGN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Exagen Inc (2012–2025)
Cash flow-to-debt ratio of Exagen Inc from 2012 to 2025. Historical debt coverage capacity for Exagen Inc across 13 annual periods. Check Exagen Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Exagen Inc Cash Flow-to-Debt Ratio by Year (2012–2025)
Exagen Inc cash flow-to-debt ratio by year from 2012 to 2025. Year-by-year debt coverage analysis for Exagen Inc. For the full cash flow conversion analysis, see XGN operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.34x | $-13.62 Million | $40.57 Million | ▲ +11.1% |
| 2024 | -0.38x | $-13.28 Million | $35.15 Million | ▲ +10.5% |
| 2023 | -0.42x | $-14.46 Million | $34.25 Million | ▲ +42.5% |
| 2022 | -0.73x | $-32.14 Million | $43.76 Million | ▼ -39.6% |
| 2021 | -0.53x | $-20.27 Million | $38.51 Million | ▼ -36.5% |
| 2020 | -0.39x | $-14.08 Million | $36.54 Million | ▼ -29.6% |
| 2019 | -0.30x | $-9.71 Million | $32.65 Million | ▼ -13.9% |
| 2018 | -0.26x | $-9.30 Million | $35.62 Million | ▲ +40.4% |
| 2017 | -0.44x | $-10.97 Million | $25.03 Million | ▼ -35.5% |
| 2015 | -0.32x | $-11.90 Million | $36.81 Million | ▲ +6.3% |
| 2014 | -0.35x | $-10.77 Million | $31.20 Million | ▲ +19.5% |
| 2013 | -0.43x | $-6.87 Million | $16.00 Million | ▲ +63.0% |
| 2012 | -1.16x | $-7.48 Million | $6.44 Million | — |